What FOXO4-DRI is
D-retro-inverso peptide designed to disrupt FOXO4-p53 interactions in senescent cells.
How it works
In preclinical models, disrupts FOXO4-p53 binding and can trigger apoptosis selectively in senescent cells.
What the evidence shows
Evidence is preclinical; human therapeutic safety and efficacy are not established.
Evidence level: E — Experimental.
Routes studied: Preclinical.
Doses studied: No validated human dosing exists. Body-weight translations of animal doses circulating online should not be treated as a human protocol.
What this page does not claim
Doses translated from animal studies are not human protocols.
Safety considerations
Systemic senescent-cell clearance could have unpredictable tissue and immune effects.
Sport and anti-doping
Unknown.
Availability at True Heal Wellness
True Heal Wellness does not offer, sell or administer FOXO4-DRI. This page exists as an educational reference only.